N
Nymbl Science
Offers balance and bladder health training through digital programs for older adults
About Nymbl Science
Nymbl Science operates in the healthcare sector, focusing on digital mobility solutions aimed at reducing fall-related medical costs. The company serves health plans and their members by providing a platform that guarantees cost savings of $3 PMPM and a 3:1 return on investment. Nymbl Science's methodology identifies the risk levels of potential fallers and intervenes before a medically-diagnosed fall occurs. This proactive approach not only reduces medical costs but also increases STAR ratings across HOS scores and boosts member retention. The business model revolves around offering a subscription-based service to health plans, with fees at risk to prove their cost-saving claims. Revenue is generated through these subscriptions, which are justified by the tangible cost savings and improved health outcomes for members.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Apr 2024 | $1.6M | $60M | Rockies Venture Club | ↗ |
| LATE VC✓Equity / VC | Feb 2023 | $880K | $3.5M | Denver Angels · Jogan Health | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Nymbl Science is 3.5K monthly website visits, up 40% over the last three months. Nymbl Science's team declined 32% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- DLDaedalus Partners LLP
Rockies Venture Club
Joyance Partners
Series A3 investors entered at this stage
Cobalt Ventures- 4V450 Ventures
Outcomes Collective
Series B and later2 investors entered at this stage
Denver Angels
Jogan Health
Other known investors10 additional known investors
Boomtown Innovation
DA Ventures
Galata Business Angels
HealthTech Capital
Paul Foley
Plug and Play
Social Starts
Tech Coast Angels- TVThird Act Ventures
Valeo Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nymbl Science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nymbl Science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.